Cormican, S., & Griffin, M. D. (2021). Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? Front Immunol.
Citación estilo ChicagoCormican, Sarah, and Matthew D. Griffin. "Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?" Front Immunol 2021.
Cita MLACormican, Sarah, and Matthew D. Griffin. "Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?" Front Immunol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.